GLP-1 safety warnings keep getting stronger, but most patients still hear the same sales pitch: “quick, easy, and safe.” Meanwhile, online prescribing makes it possible to get powerful medications with almost no evaluation—sometimes faster than you can book a primary care visit. In this episode, Andy and I talk about what patients aren’t being told: why these warnings matter, how “questionnaire medicine” shifts risk onto you, and why relationship-based care protects you when medications aren’t harmless.
Watch the Podcast Episode
Get the full story in our latest episode—watch now, and don’t forget to subscribe to our YouTube channel for more insight and honest conversation.
Download the Transcript (PDF)
GLP-1 safety warnings: the hype is outrunning the medicine
GLP-1 drugs are being treated like a lifestyle accessory—something you take to “tighten up” before a wedding, keep up with your friends, or lose 10–15 pounds. That’s not what these medications were built for, and it’s not how risk works in real life.
One of the most important points Andy made in this episode of the Return to Healing Podcast, is that when you start seeing serious harms this early in a drug’s lifecycle, you should pay attention—because a lot of drug damage doesn’t show up immediately. Some harms take 10, 20, even 30 years to become obvious. In other words: we may not even fully understand the long-term consequences in our lifetime.
That doesn’t mean GLP-1s should never be used. In fact, for many people with severe obesity, major weight loss could be life-saving, and the risk/benefit conversation can look very different. But the way these drugs are being positioned for “vanity” use—especially through online funnels—is where things get reckless.
Why online prescribing makes GLP-1 risks worse
Prescribing medications to people you’ve never met, based on two or three questions and a checkbox, is dangerous.
I tried one of these platforms myself, just to see what the process looked like. The questions were minimal, and about a minute later the system essentially said: approved; that isn’t a medical evaluation, it’s a sales workflow with legal cover.
And that’s the core problem: the company gets paid for the transaction, but when something goes wrong—when a patient has a severe reaction or a potential complication from any GLP-1 safety warnings—who takes responsibility? These businesses can’t manage acute side effects the way a real clinician-patient relationship can. They sell the product, and the real healthcare system cleans up the mess.
“Emergency antibiotic kits” are a perfect example of how unsafe this can get
What pushed me over the edge was seeing an “emergency medicine kit” marketed to include a list of symptoms and tells people which antibiotic (or other drug) to take—without a real exam, vitals, or a clinician who knows them. The kit I looked at was presented as if it was responsible self-care. In reality, it’s a setup for bad outcomes.
The kit I saw had about 15 antibiotics and even included ivermectin recommendations for things like COVID. The idea that you can hand someone a medication buffet and say “choose your own adventure” is not evidence-based medicine—it’s a malpractice mindset wrapped in marketing.
Even more disturbing: the barrier to purchase was essentially “confirm your age” and “confirm you’re not allergic”—and you’re done. No vitals. No oxygen saturation. No listening to lungs. No way to distinguish a cold from pneumonia or meningitis.
Why this is exploding: people hate the system—and primary care is disappearing
Andy put his finger on the uncomfortable truth that many people hate the medical system. They’ve waited too long, paid too much, and felt dismissed. And the primary care shortage is real—people can’t find appointments, and some practices aren’t accepting new patients. These companies aren’t fixing that crisis; they’re exploiting it.
But the “solution” can’t be medicine without medicine.
Because what gets lost is the thing that actually saves lives: relationship-based primary care—a clinician who knows your baseline, can monitor risk over time, can guide prevention, and can respond when something changes. A questionnaire can’t do that.
What to do if you’re considering a GLP-1 or any online prescription
1) Treat GLP-1s like serious medicine, not a cosmetic tool
If you’re truly a good candidate, have the conversation in a setting where someone can monitor you—and where the GLP-1 safety risks are discussed honestly.
2) Don’t “self-prescribe” antibiotics from a kit
If you’re sick enough to consider antibiotics, you’re sick enough to be evaluated. At minimum, someone needs to check vital signs and assess you properly.
3) Don’t confuse convenience with care
Fast access is not the same thing as good medicine. Real care includes follow-up and accountability—especially when something goes wrong.
Closing thoughts
We’re watching medicine get pulled backward—toward a world where the loudest marketing wins, the “doctor” is a brand, and prescriptions are product lines.
GLP-1 weight loss shot risks deserve serious, individualized conversations—not a checkbox funnel. And antibiotic kits don’t protect people; they tempt people into treating serious illness without the most basic evaluation.
Healthcare needs reform, but turning medicine into retail isn’t reform. It’s surrender.
Want safer care—not a checkout screen?
If you’re considering a GLP-1, dealing with recurrent infections, or feeling pushed toward online “quick fixes,” talk with a clinician who can actually follow you over time, and effectively discuss potential GLP-1 safety risks as they might apply to you as a patient, instead of an shopping cart. Download the transcript, watch the full episode, and share this with someone who’s being marketed medicine instead of receiving care.
→ Watch the episode on YouTube
→ Explore more episodes + articles
Reviewer note
Written by Dr. Alan Roth, D Medically reviewed by Dr. Andy Lazris, MD.
GLP-1 risks and FAQs
1) What are the most common GLP-1 weight loss shot safety risks?
Short answer covering GI safety risks and side effects, dehydration, gallbladder issues, pancreatitis warning context, and why monitoring matters.
2) Are GLP-1 medications “unsafe” for everyone?
Clarify risk/benefit, who may benefit most, and why “vanity use” changes the calculus.
3) Is online prescribing always bad?
Differentiate telehealth as a tool vs. questionnaire-only prescribing without real follow-up.
4) Why are “emergency antibiotic kits” risky?
Explain misdiagnosis, side effects/allergy risk, C. diff, resistance, and delayed care.
5) When should antibiotics be used?
Give a plain-language rule: confirmed bacterial infection + clinician evaluation + right drug/dose/duration.
6) What should I do if I already have a kit or I’m already on a GLP-1?
Practical next steps: don’t self-treat; talk to your clinician; seek urgent care for red flags; ask for monitoring plan.
